<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04566523</url>
  </required_header>
  <id_info>
    <org_study_id>2019-102868-49</org_study_id>
    <nct_id>NCT04566523</nct_id>
  </id_info>
  <brief_title>TeleRehabilitation for Patients With Chronic Respiratory Failure.</brief_title>
  <acronym>e-mouv</acronym>
  <official_title>Clinical Benefits of TeleRehabilitation in Chronic Respiratory Failure Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SOS Oxygene Mediterranee</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SOS Oxygene Mediterranee</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is widely described in the literature that exercise training improves patients' exercise&#xD;
      tolerance, quality of life, symptoms, anxiety and depression, regardless of the location.&#xD;
      Despite overwhelming evidence of the benefits of exercise training, only a very small&#xD;
      percentage of eligible people have ever completed a program. Alternative modes of exercise&#xD;
      training are needed to improve equity of access for patients with chronic respiratory&#xD;
      disease. So TeleRehabilitation, using information and communication technologies to provide&#xD;
      distance exercise training services, may be an answer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>exercise tolerance</measure>
    <time_frame>3 month after inclusion</time_frame>
    <description>number of steps during 6 minute stepper test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>exercise tolerance</measure>
    <time_frame>6 month and one year after inclusion</time_frame>
    <description>number of steps during 6 minute stepper test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VQ-11</measure>
    <time_frame>3, 6 month and 1 year after inclusion</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>physical activity quantity</measure>
    <time_frame>3, 6 month and 1 year after inclusion</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Chronic Respiratory Disease</condition>
  <condition>Exercise</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Chronic respiratory patients who undergo a home-based exercise training program with a rehabilitation coach supervision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tele Group</arm_group_label>
    <description>Chronic respiratory patients who undergo a home-based exercise training program online.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>telerehabilitation</intervention_name>
    <description>Patients undergo an online exercise training program via a certified host of health data website.</description>
    <arm_group_label>Tele Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients from medical consultation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  chronic respiratory disease patients&#xD;
&#xD;
          -  Patients with dyspnea or exercise intolerance.&#xD;
&#xD;
          -  Stable patients at home.&#xD;
&#xD;
          -  Patients who can use a computer (after explanations) and have adequate hearing and&#xD;
             vision.&#xD;
&#xD;
          -  Collection of the patient's non-objection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Life expectancy &lt;3 months.&#xD;
&#xD;
          -  Absolute contraindication to performing physical activity&#xD;
&#xD;
          -  Hospitalization for exacerbation in the two months prior to inclusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>william Heurtaux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>clinique des Cèdres</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>delphine delample, PhD</last_name>
    <phone>+33612155648</phone>
    <email>d.delample@sosoxygene.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cabinet de pneumologie Clinique des Cèdres</name>
      <address>
        <city>Cornebarrieu</city>
        <zip>31700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>william Heurtaux, MD</last_name>
      <phone>05 62 13 32 01</phone>
      <email>william.heutaux@free.fr</email>
    </contact>
    <investigator>
      <last_name>Daniel Bajon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Odile Sizaret, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvain Droneau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>October 12, 2020</last_update_submitted>
  <last_update_submitted_qc>October 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

